Tatva Chintan Pharma Chem Ltd

NSE: TATVA · BSE: 543321 · Chemicals & Petrochemicals · 32 announcements

Tatva Chintan Pharma Chem Ltd news stories on ALFA NewsRead the news →

Share price: ₹1,655.00
Market cap: ₹3,871 Cr
Revenue (annual): ₹505.9 Cr
Net profit (annual): ₹42.05 Cr
P/E (TTM): 61.5×Sector 35.5×
Promoter holding: 72.02%+0.00% QoQ
FII holding: 4.38%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 7 Other Announcement 4 Financial Results 4 Board Meeting Date 3 Annual General Meeting 3 Management Change 2 Debt & Borrowing 2 Capacity Expansion 2 Dividend 1 Credit Rating 1 Business Update 1 Board Meeting Outcome 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

20 Jul 2026 18:48 IST NSE

Capacity ExpansionAlfa Alert

Tatva Chintan Pharma Chem Capacity Expansion

Tatva Chintan Pharma Chem held a groundbreaking ceremony for a new greenfield manufacturing unit at Dahej-III, Gujarat. This expansion supports the company's long-term growth strategy.

Open announcement → Read the story on ALFA News Read the filing ↗

17 Jul 2026 15:46 IST NSE

Capacity ExpansionAlfa Alert

Tatva Chintan Pharma Chem Capacity Expansion: ₹200 Cr Investment

Tatva Chintan approved a Rs. 200 Crore greenfield expansion at Dahej-III, adding 344 KL reactor capacity. The board also re-appointed key directors and reported quarterly results.

Value: ₹200.0 Cr
Execution: 21 months

Open announcement → Read the story on ALFA News Read the filing ↗